1.NextEra Energy, Inc.
NEE (NYSE)
NextEra Energy, Inc. stands out in the utility and renewable energy sector, known for its stable cash flows and defensive characteristics. With a dividend yield of 2.77% and a notable 1-year return of 25.78%, it presents an attractive option for income-focused investors. Analysts have a favorable outlook, assigning a B+ rating and setting a 12-month price target that ranges from $91 to $116.
Pros:
- Strong focus on renewable energy
- Stable cash flows
Cons:
- Market sensitivity to energy prices
- Regulatory risks
2.Procter & Gamble Company
PG (NYSE)
Procter & Gamble is a diversified U.S. household and personal-care goods leader that benefits from recurring demand and exhibits strong pricing power. With a dividend yield of 2.91% and a five-year return of 5.27%, it remains an attractive investment for those seeking reliable income from financially healthy companies. Analysts maintain a favorable outlook, assigning a median price target of $162.50, with ratings ranging from Equal Weight to Buy.
Pros:
- Strong brand portfolio
- Recurring demand for consumer products
Cons:
- Recent negative return
- Market competition
3.Medtronic plc
MDT (NYSE)
Medtronic plc stands out as a recession-resistant healthcare device company, offering essential medical products that appeal to risk-averse investors. With a dividend yield of 3.52%, it provides a reliable income stream despite recent challenges, reflected in a one-year return of -8.37% and a five-year return of -35.29%. Analysts maintain a positive outlook, with a median 12-month price target of $91.00 and a solid B+ rating, underscoring its potential for future recovery.
Pros:
- Diverse product portfolio in healthcare
- Recession-resistant stock
Cons:
- Recent negative returns
- Market competition
4.Costco Wholesale Corporation
COST (NASDAQ)
Costco Wholesale Corporation stands out as a resilient retailer with a value-oriented model, making it appealing during times when consumers are more price-sensitive. With a solid 1-year return of 1.18% and an impressive 5-year return of 122.70%, it’s an attractive option for investors seeking consistent performance. Analysts have a median 12-month price target of $1,100, with a strong analyst rating of B+, highlighting its potential for future growth.
Pros:
- Membership-based recurring revenue
- Value-oriented model
Cons:
- Low dividend yield
- Dependence on consumer spending
5.Johnson & Johnson
JNJ (NYSE)
Johnson & Johnson stands out as a top-rated healthcare company, known for its diverse product offerings in a defensive sector that typically performs well during economic downturns. The stock boasts a solid dividend yield of 2.00% and impressive returns of nearly 60% over the past year, making it an attractive option for investors seeking reliable income and growth potential. Analysts are optimistic, with a median 12-month price target of $272, supported by solid ratings from firms like Guggenheim and RBC Capital.
Pros:
- Strong dividend yield
- Defensive sector with stable demand
Cons:
- Market volatility risk
- Dependence on healthcare regulations
6.Walmart Inc.
WMT (NYSE)
Walmart Inc. stands out as a top-rated consumer staples retailer, benefiting from steady demand for everyday essentials, especially during economic downturns. With a solid dividend yield of 0.90% and impressive returns of 13.54% over the past year and 133.08% over five years, it’s an attractive option for investors seeking reliable income from financially healthy companies. Analysts maintain a positive outlook, with a median 12-month price target of $140.00, supported by ratings from RBC Capital and BTIG as "Outperform" and "Buy," respectively.
Pros:
- Strong market presence
- Steady demand for essentials
Cons:
- Low dividend yield
- Market competition from e-commerce
7.Coca-Cola Company
KO (NYSE)
Coca-Cola Company stands out as a robust player in the beverage sector, renowned for its global brand strength and consistent demand for affordable products, even during economic downturns. With a dividend yield of 2.55% and impressive 1-year and 5-year returns of 21.96% and 45.03%, respectively, KO appeals to investors seeking reliable income from financially healthy companies. Analysts maintain a consensus rating of Buy, with a median 12-month price target of $87.50, reflecting strong confidence in its ongoing performance.
Pros:
- Strong global brand
- Resilient demand in weak economies
Cons:
- Dependence on sugary beverage market
- Health trends affecting sales
Final Words
As you consider your investment options during this recessionary period, remember that stocks like Johnson & Johnson can provide stability and potential growth. Take time to compare these alternatives and conduct your own research to ensure your portfolio aligns with your financial goals.
Frequently Asked Questions
Johnson & Johnson has shown strong performance with a YTD return of 28.41% and a 1-year return of 59.87%. Additionally, the stock has a 3-year return of 53.00% and a 5-year return of 53.91%.
Johnson & Johnson offers a dividend yield of approximately 2.00%. The next dividend payment is scheduled for September 8, 2026, at $1.34 per share.
Johnson & Johnson operates in the healthcare sector, which is often seen as defensive during economic downturns. Its diversified range of products and services helps it maintain stability when consumer spending decreases.
As of now, Johnson & Johnson has a market capitalization of approximately $639.69 billion. This reflects its strong position in the healthcare industry and investor confidence.
Johnson & Johnson has shown impressive returns compared to many stocks in the healthcare sector. Its consistent performance, highlighted by a 10-year return of 112.98%, makes it a strong contender among peers.
While Johnson & Johnson is generally considered a stable investment, risks include regulatory changes, patent expirations, and potential lawsuits affecting its product lines. Investors should stay informed about these factors when considering JNJ.


